Evelo Biosciences, Inc.

EVLOOTCHealthcare● Active

$0.00

+$0.00(+0.00%)

Market Cap$1898

P/E Ratio—

52W High$0.0006

52W Low$0.0001

Avg Volume346

Open$0.00

Beta1.32

Earnings Financials Revenue

Evelo Biosciences, Inc. (EVLO) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

EVLO · earnings · updated Jun 8, 2026

Latest Earnings

Q4 FY2023Report Date: Nov 9, 2023

EPS Actual

-$0.66

Est. -$1.34 · +50.8%

Revenue

—

Fiscal Period

Q4 FY2023

FY ends December

Report Date

Nov 9, 2023

After Market Close

▲ Beat EPS✓ 1-Quarter EPS Beat Streak

EVLO reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Days Away85

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
◌ Q3 FY2026	Aug 10, 2026	-$10.40	—	—	—	—	—
◌ Q2 FY2026	May 14, 2026	-$10.40	—	—	—	—	—
◌ Q1 FY2026	Mar 19, 2026	-$10.13	—	—	—	—	—
◌ Q4 FY2025	Nov 24, 2025	—	—	—	—	—	—
◌ Q2 FY2025	Jun 4, 2025	—	—	—	—	—	—
◌ Q2 FY2025	May 29, 2025	—	—	—	—	—	—
◌ Q1 FY2025	Mar 28, 2025	—	—	—	—	—	—
◌ Q4 FY2024	Dec 26, 2024	—	—	—	—	—	—

Q3 FY2026

Aug 10, 2026

EPS Actual

—

EPS Est.

-$10.40

EPS Surpr.

—

Revenue

—

Q2 FY2026

May 14, 2026

EPS Actual

—

EPS Est.

-$10.40

EPS Surpr.

—

Revenue

—

Q1 FY2026

Mar 19, 2026

EPS Actual

—

EPS Est.

-$10.13

EPS Surpr.

—

Revenue

—

Q4 FY2025

Nov 24, 2025

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2025

Jun 4, 2025

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2025

May 29, 2025

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2025

Mar 28, 2025

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2024

Dec 26, 2024

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Analyst Estimates

Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.

EPS Estimates

Period	Low	Consensus	High	# Analysts
Q3 FY2030	$-0.38	$-0.38	$-0.38	1
Q2 FY2030	$-0.43	$-0.43	$-0.43	1
Q1 FY2030	$-0.48	$-0.48	$-0.48	1
Q4 FY2029	$-0.38	$-0.38	$-0.38	1
Q3 FY2029	$-0.43	$-0.43	$-0.43	1
Q2 FY2029	$-0.48	$-0.48	$-0.48	1

Revenue Estimates

Period	Low	Consensus	High
Q3 FY2030	$0.0B	$0.0B	$0.0B
Q2 FY2030	$0.0B	$0.0B	$0.0B
Q1 FY2030	$0.0B	$0.0B	$0.0B
Q4 FY2029	$0.0B	$0.0B	$0.0B
Q3 FY2029	$0.0B	$0.0B	$0.0B
Q2 FY2029	$0.0B	$0.0B	$0.0B

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
▲ Q4 FY2023	Nov 9, 2023	+50.8%	$0.33	$0.33	-0.70%

Q4 FY2023-0.70%

Report Date

Nov 9, 2023

EPS Beat/Miss

+50.8%

Price Before

$0.33

Price After

$0.33

Avg Beat Reaction-0.70%

Beat Rate1 / 1 quarters

Largest Move-0.70% (Q4 FY2023)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Evelo Biosciences, Inc. (EVLO) most recently reported earnings on November 9, 2023 for Q4 FY2023, posting EPS of $-0.66 — beating the analyst consensus of $-1.34 by +50.8%. The next EVLO earnings date is expected around September 1, 2026.

Each quarter, investors track EVLO earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. EVLO revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

EVLO's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

EVLO earnings · 5 questions

Evelo Biosciences, Inc.'s next earnings report is expected around September 1, 2026. EVLO typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; EVLO historically reports after market close (AMC).

EVLO earnings datewhen is EVLO earningsEVLO next earnings datewhen does EVLO report earningsEVLO earnings calendar

▸ Source: FMP · Evelo Biosciences, Inc. SEC filings · US GAAP · Evelo Biosciences, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026